Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience
Despite clinical benefits of long-acting muscarinic antagonist (LAMA)/long-acting beta2-agonist (LABA) double bronchodilator therapy, there has been limited evidence for treatment change from LAMA/LABA to inhaled corticosteroid (ICS)-containing therapy. This study aimed to assess the rate of ICS-con...
Main Authors: | Sun Hye Shin, Noeul Kang, Juhee Cho, Yeonseok Choi, Hyun Kyu Cho, Hye Sook Choi, Hojoong Kim, Jun Hyeok Lim, Hye Yun Park |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/8/2547 |
Similar Items
-
Dual Bronchodilator in the Era of Triple Therapy
by: Papaioannou AI, et al.
Published: (2020-10-01) -
The role of inhaled and/or nasal corticosteroids on the bronchodilator response
by: Ju Kyung Lee, et al.
Published: (2010-11-01) -
GOLD 2021 Strategy Report: Implications for Asthma–COPD Overlap
by: Roman-Rodriguez M, et al.
Published: (2021-06-01) -
Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
by: Tashkin DP, et al.
Published: (2018-08-01) -
Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD
by: Yamauchi Y, et al.
Published: (2016-06-01)